SG11201804067QA - Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives - Google Patents

Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives

Info

Publication number
SG11201804067QA
SG11201804067QA SG11201804067QA SG11201804067QA SG11201804067QA SG 11201804067Q A SG11201804067Q A SG 11201804067QA SG 11201804067Q A SG11201804067Q A SG 11201804067QA SG 11201804067Q A SG11201804067Q A SG 11201804067QA SG 11201804067Q A SG11201804067Q A SG 11201804067QA
Authority
SG
Singapore
Prior art keywords
international
synthesis
pct
preparing
philadelphia
Prior art date
Application number
SG11201804067QA
Other languages
English (en)
Inventor
Sheng Xu
Yihui Xu
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of SG11201804067QA publication Critical patent/SG11201804067QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/16Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00Formation or introduction of functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • C07C251/74Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/76Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of a saturated carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Road Paving Structures (AREA)
SG11201804067QA 2015-11-18 2016-11-14 Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives SG11201804067QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562256825P 2015-11-18 2015-11-18
PCT/US2016/061842 WO2017087323A1 (en) 2015-11-18 2016-11-14 Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives

Publications (1)

Publication Number Publication Date
SG11201804067QA true SG11201804067QA (en) 2018-06-28

Family

ID=58717701

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201804067QA SG11201804067QA (en) 2015-11-18 2016-11-14 Process for the synthesis of intermediates useful for preparing 1,3,4-triazine derivatives

Country Status (17)

Country Link
US (1) US10294196B2 (ja)
EP (1) EP3377470B1 (ja)
JP (1) JP2018534315A (ja)
KR (1) KR20180081599A (ja)
CN (1) CN108349868A (ja)
AR (1) AR106706A1 (ja)
AU (1) AU2016358147A1 (ja)
BR (1) BR112018010041A2 (ja)
CA (1) CA3005261A1 (ja)
HU (1) HUE052157T2 (ja)
IL (1) IL259332A (ja)
MX (1) MX2018006158A (ja)
MY (1) MY185271A (ja)
RU (1) RU2728874C2 (ja)
SG (1) SG11201804067QA (ja)
TW (1) TWI643839B (ja)
WO (1) WO2017087323A1 (ja)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652709A5 (de) 1983-01-06 1985-11-29 Lonza Ag Verfahren zur herstellung von estern der mesoxalsaeure.
IT1175533B (it) 1984-06-20 1987-07-01 Montedison Spa Processo per la preparazione di composti carbonilici
IT1233862B (it) 1988-02-24 1992-04-21 Mini Ricerca Scient Tecnolog Processo catalitico per la sintesi di esteri di acidi etilentetracarbossilici.
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
DE4309900C1 (de) 1993-03-26 1994-06-30 Goldschmidt Ag Th Verfahren zur Herstellung von amphoteren Tensiden
MY149960A (en) * 2005-05-18 2013-11-15 Array Biopharma Inc 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases
DE102006053380A1 (de) 2006-11-13 2008-05-15 Wacker Chemie Ag Verfahren zur Herstellung von chlorierten Carbonylverbindungen in Jet Loop Reaktoren
WO2008120004A1 (en) * 2007-04-02 2008-10-09 Astrazeneca Ab Combination of a mek- inhibitor and a b-raf inhibitor for the treatment of cancer
KR20100089082A (ko) * 2007-10-15 2010-08-11 아스트라제네카 아베 조합 059
MY155641A (en) 2009-06-26 2015-11-13 Ihara Chemical Ind Co Process for production of ketomalonic acid compounds or hydrates thereof
WO2011095807A1 (en) * 2010-02-07 2011-08-11 Astrazeneca Ab Combinations of mek and hh inhibitors
EA022864B1 (ru) * 2010-06-29 2016-03-31 Фмк Корпорейшн Производные 6-ацил-1,2,4-триазин-3,5-диона и гербициды
WO2014031971A1 (en) * 2012-08-24 2014-02-27 E. I. Du Pont De Nemours And Company Herbicidal pyridazinones
GB201403495D0 (en) * 2014-02-27 2014-04-16 Syngenta Participations Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
AR106706A1 (es) 2018-02-07
AU2016358147A1 (en) 2018-05-31
MX2018006158A (es) 2018-08-01
WO2017087323A1 (en) 2017-05-26
US20180334427A1 (en) 2018-11-22
EP3377470A1 (en) 2018-09-26
US10294196B2 (en) 2019-05-21
KR20180081599A (ko) 2018-07-16
RU2018121809A (ru) 2019-12-18
TWI643839B (zh) 2018-12-11
HUE052157T2 (hu) 2021-04-28
MY185271A (en) 2021-04-30
CN108349868A (zh) 2018-07-31
BR112018010041A2 (pt) 2018-11-21
EP3377470B1 (en) 2020-11-11
JP2018534315A (ja) 2018-11-22
IL259332A (en) 2018-07-31
RU2728874C2 (ru) 2020-07-31
TW201726608A (zh) 2017-08-01
CA3005261A1 (en) 2017-05-26
EP3377470A4 (en) 2019-07-31
RU2018121809A3 (ja) 2020-01-27

Similar Documents

Publication Publication Date Title
SG11201804915RA (en) Methods for treating huntington's disease
SG11201810983PA (en) Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201908813QA (en) Anti-sirp alpha antibodies
SG11201908820VA (en) Novel heterocyclic derivatives useful as shp2 inhibitors
SG11201807252QA (en) Anti-lag-3 antibodies
SG11201903487SA (en) PROCESS FOR THE PREPARATION OF PYRAZOLO[1,5-a]PYRIMIDINES AND SALTS THEREOF
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201809499UA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201804098TA (en) Purinones as ubiquitin-specific protease 1 inhibitors
SG11201804758QA (en) Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201808476SA (en) Recycling of polymer matrix composite
SG11201804223TA (en) OCTAHYDROPYRROLO [3, 4-c] PYRROLE DERIVATIVES AND USES THEREOF
SG11201810965YA (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
SG11201810525XA (en) Anti-gitr antibodies and uses thereof
SG11201804712PA (en) Biofuel
SG11201811161YA (en) Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
SG11201903076QA (en) Carbamoyl phenylalaninol compounds and uses therof
SG11201803918VA (en) Production of steviol glycosides in recombinant hosts
SG11201909807TA (en) Methods of manufacturing of niraparib
SG11201809497RA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201804589TA (en) Piperidinone formyl peptide 2 receptor and formyl peptide 1 receptor agonists
SG11201804774YA (en) Diastereoselective synthesis of phosphate derivatives and of the gemcitabine prodrug nuc-1031
SG11201907356SA (en) Piperidine-substituted mnk inhibitors and methods related thereto
SG11201808221QA (en) 1,5-dihydro-4h-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4h-pyrazolo[4,3-c]pyridin-4-ones as pde1 inhibitors